HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum

被引:19
|
作者
Theodore, Shaji [1 ]
Cass, Wayne A. [2 ]
Dwoskin, Linda P. [3 ]
Maragos, William F. [1 ,4 ]
机构
[1] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA
[2] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[3] Univ Kentucky, Sch Pharm, Lexington, KY 40536 USA
[4] Hunter Holmes McGuire Vet Adm, Neurol Serv, Richmond, VA 23249 USA
关键词
dopamine; neurodegeneration; basal ganglia; striatum; AIDS DEMENTIA; METHAMPHETAMINE; DYSFUNCTION; DECREASES; DOPAMINE;
D O I
10.1002/syn.21564
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:755 / 757
页数:3
相关论文
共 50 条
  • [21] Methylenedioxypryovalerone (MDPV) Rapidly Increases Dopamine Transporter and Vesicular Monoamine Transporter-2 Function
    German, Christopher L.
    Magee, Charlotte P.
    Curtis, Peter S.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    FASEB JOURNAL, 2018, 32 (01):
  • [22] Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein
    Truong, JG
    Newman, AH
    Hanson, GR
    Fleckenstein, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (1-2) : 27 - 32
  • [23] GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2
    Nickell, Justin R.
    Siripurapu, Kiran B.
    Horton, David B.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 795 : 143 - 149
  • [24] Risperidone, an atypical antipsychotic, affects the mRNA expressions of monoamine oxidase type B and vesicular monoamine transporter-2 in rat brain
    Ota, M
    Nakashima, A
    Mori, K
    Hamanaka, T
    Ota, A
    BIOGENIC AMINES, 1999, 15 (02) : 197 - 216
  • [25] The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2
    Requena, Daniela F.
    Parra, Leonardo A.
    Baust, Tracy B.
    Quiroz, Marisol
    Leak, Rehana K.
    Garcia-Olivares, Jennie
    Torres, Gonzalo E.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (02) : 581 - 594
  • [26] Expression and voltammetric monitoring of vesicular monoamine transporter-2 in Xenopus laevis oocytes
    Whitley, JL
    Near, JA
    FASEB JOURNAL, 1998, 12 (04): : A456 - A456
  • [27] Methylphenidate redistributes vesicular monoamine transporter-2 immunoreactivity: Role of dopamine receptors
    Sandoval, V
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2002, 16 (04): : A585 - A585
  • [28] Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2
    Riddle, Evan L.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 571 (01) : 25 - 28
  • [29] Regulation of the vesicular monoamine transporter-2: A novel mechanism for cocaine and other psychostimulants
    Brown, JM
    Hanson, GR
    Fleckenstein, AE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 296 (03): : 762 - 767
  • [30] Curcumin inhibits HIV-1 by promoting Tat protein degradation
    Ali, Amjad
    Banerjea, Akhil C.
    SCIENTIFIC REPORTS, 2016, 6